How to appeal a CareFirst BCBS pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

CareFirst BCBS-specific note: BCBS licensee for Maryland, DC, and northern Virginia (~3.5M members). Operates as non-profit. Appeals jurisdiction depends on policy issue location — MIA (MD), DISB (DC), or SCC Bureau of Insurance (VA). CVS Caremark is the PBM.

What CareFirst BCBS's policy requires for pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology

Cited policy: Anthem clinical guideline Growth Hormone + BCBS Medical Policy on Somatropin (mirrors PES Grimberg HRP 2016)

PES Pediatric GH Use Recommendations (Grimberg Horm Res Paediatr 2016): GHD requires height <=-2.25 SD AND HV <-1 SD AND IGF-1 / IGFBP-3 low AND peak GH <10 ng/mL on 2 provocative stimuli (insulin tolerance, arginine, clonidine, glucagon). ISS criteria + Turner / Noonan / SGA / SHOX / PWS specific criteria.

How CareFirst BCBS denies pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology — and how to counter it

Where CareFirst BCBS pushes back: 1) Single GH stim test not adequate; 2) Bone age + IGF-1 not documented; 3) ISS 'not medically necessary'; 4) Dose questioned.

Counter-arguments that hold up: Cite PES Grimberg HRP 2016. Submit growth chart with height/velocity SDs over time, bone age (Greulich-Pyle), IGF-1 + IGFBP-3, MRI brain to rule out hypothalamic-pituitary lesion, two GH stim tests with peak. For Turner: karyotype 45,X. For SGA: birth weight/length <-2 SD with no catch-up by age 4. For SHOX: SHOX gene mutation. For Noonan: PTPN11 / SOS1. Peds endo prescribing.

What CareFirst BCBS typically denies for pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology

Across CareFirst BCBS's commercial and Medicare books, denials cluster around a small number of patterns. For pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology, expect:

• DC/MD/VA cross-jurisdiction issues
• Step therapy on specialty drugs via CVS Caremark
• Behavioral health network adequacy
• BlueChoice HMO referral denials

Treatments most often denied in this category

These are the pediatric subspecialty — cardiology, gi, pulmonology, rheumatology, endocrinology, neurology treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Peds congenital heart surgery
• Kawasaki workup + IVIG
• Pediatric ECMO
• Peds EoE workup + therapy
• Peds IBD biologic
• Peds asthma biologic / admission

How to submit the appeal to CareFirst BCBS

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document CareFirst BCBS cited in the denial.
3. File the appeal through CareFirst BCBS's portal (members: https://member.carefirst.com ; providers: https://provider.carefirst.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MD, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See CareFirst BCBS's prior-authorization criteria by drug: CareFirst BCBS PA criteria on ApprovalHelp.